StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
RaQualia Pharma Inc.
Tokyo Stock Exchange:4579.T
Sector
Location
Market Cap
USD 89.17 M
Share Price
USD 3.64
Avg Daily Volume
298,219
Change (1 day)
1.88%
Change (1 year)
-0.46%
Change (YTD)
48.63%
RaQualia Pharma Inc. Receivables for the year ending December 31, 2024: USD 4.38 M
RaQualia Pharma Inc. Receivables is USD 4.38 M for the year ending December 31, 2024, a 2.53% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
-
RaQualia Pharma Inc. Receivables for the year ending December 31, 2023 was USD 4.27 M, a -6.91% change year over year.
-
RaQualia Pharma Inc. Receivables for the year ending December 31, 2022 was USD 4.59 M, a -56.14% change year over year.
-
RaQualia Pharma Inc. Receivables for the year ending December 31, 2021 was USD 10.47 M, a 103.83% change year over year.
-
RaQualia Pharma Inc. Receivables for the year ending December 31, 2020 was USD 5.14 M, a -25.28% change year over year.
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.30
4506.T
+0.02
0.27%
Guobang Pharma Ltd.
USD 2.77
605507.SS
-0.00
-0.14%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Zoetis Inc.
USD 159.08
ZTS
-0.11
-0.07%
Key Data
| Date | Receivables | Inventory | Current Assets | Property, Plant, Equipment (Net) |
|---|
Competitors
Sumitomo Pharma Co., Ltd.
USD 6.30
4506.T
+0.02
0.27%
Guobang Pharma Ltd.
USD 2.77
605507.SS
-0.00
-0.14%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
CSL Limited
USD 159.11
CSL.AX
+1.27
0.80%
Zoetis Inc.
USD 159.08
ZTS
-0.11
-0.07%